GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As

Group 1 - GE HealthCare Technologies (NASDAQ: GEHC) is expected to see revenue growth due to a strong backlog and the deployment of stimulus funding in China [1] - The company is launching new products, including Flyrcado, which will contribute to its revenue growth alongside organic growth [1] - GE HealthCare is well-positioned for bolt-on mergers and acquisitions, enhancing its growth strategy [1]